LICENSE AGREEMENT between NOVARTIS PHARMA AG and MIDATECH LIMITED Dated as of 6 June 2017License Agreement • July 19th, 2017 • Midatech Pharma PLC • Pharmaceutical preparations • Delaware
This License Agreement (the “Agreement”) is made and entered into effective as of 6 June 2017 (the “Effective Date”) by and between Novartis Pharma AG, a company organized under the laws of Switzerland, having its principal place of business at Forum 1, Novartis Campus, 4056 Basel, Switzerland (“Novartis”) and Midatech Limited, a company incorporated in England and Wales under registration number 04097593, whose registered office is at 65 Innovation Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RQ United Kingdom (“Midatech”). Novartis and Midatech are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
